CeGaT upgrades its Epilepsy Panel

Based on the latest research further genes have been added to the existing Epilepsy panel. Furthermore we have introduced 6 new subpanels. We are now offering 20 Epilepsy subpanels with in total 327 genes: Epilepsy Subpanel 1: Generalized / Myoclonic Epilepsy, Febrile Seizures, Absences (now 38 genes) Epilepsy Subpanel 2: Epileptic Encephalopathies (now 30 genes) […]

CeGaT is finalist at the German Founder Award

Today it was announced that CeGaT is one of the three finalists of the German Founders Award in the category “StartUp”. The jury states as reason: “… because the company bundles the know-how of medical professionals, scientists and bioinformaticians, and reaches a new level in the analysis of genomes.” We are delighted to receive this […]

CeGaT at the NewCome

Ernst Pfister opened the NewCome 2011 at the Messe Stuttgart with the words: “Interested founder with innovative and sustainable business ideas can help in starting a makeover to our economy!”. To describe the short but very successful career of CeGaT Saskia Biskup she is invited along with two other founders to a panel discussion (chaired […]

CeGaT upgrades to SOLiD 5500xl

Beginning of 2011 CeGaT has ordered the SOLiD 5500xl system. As official service provider of Applied Biosystems / life technologies we will be among the first using this technology. Per run we will be able to generate up to 180 Gb (= bases). With the new nanobeads which will be available soon this output […]

CeGaT, JSW, and NMI work on novel Alzheimer’s Disease Models

CeGaT, JSW Lifesciences GmbH, Grambach, Austria, and NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany, today announced that they will develop novel models for Alzheimer’s and related diseases based on the mitochondrial cascade hypothesis. Within the three year project, knocking-down of mitochondrial proteins will be used to elucidate the specific involvement of […]